|
14 Jun 2020 |
AstraZeneca to supply Europe with up to 400 million doses of Oxford University’s vaccine at no profit
|
|
14 Jun 2020 |
Sinovac Announces Positive Preliminary Results of Phase I/II Clinical Trials for Inactivated Vaccine Candidate Against COVID-19
|
|
13 Jun 2020 |
Calquence showed long-term efficacy and tolerability for patients with chronic lymphocytic leukaemia in two trials
|
|
13 Jun 2020 |
FDA Approves Merck’s GARDASIL 9 for the Prevention of Certain HPV-Related Head and Neck Cancers
|
|
11 Jun 2020 |
Moderna Advances Late-Stage Development of its Vaccine (mRNA-1273) Against COVID-19
|
|
11 Jun 2020 |
Sinovac and Butantan Join Efforts to Advance the Clinical Development of An Inactivated Vaccine for COVID-19 to Phase III
|
|
11 Jun 2020 |
Catalent Partners with Spicona to Develop COVID-19 Vaccine Candidate using GPEx Cell Line Development Platform
|
|
10 Jun 2020 |
Johnson & Johnson Announces Acceleration of its COVID-19 Vaccine Candidate; Phase 1/2a Clinical Trial to Begin in Second Half of July
|
|
10 Jun 2020 |
Panacea Biotec and Refana Announce Landmark Collaboration for COVID-19 Vaccine
|
|
10 Jun 2020 |
UbiVac Announces Clinical Trial Collaboration with Bristol Myers Squibb on Combination Immunotherapy for Advanced Triple Negative Breast Cancer
|
|
08 Jun 2020 |
Bavarian Nordic Announces Topline Results from Phase 1 Clinical Trial of Equine Encephalitis Virus Vaccine
|
|
08 Jun 2020 |
The University of Queensland, CEPI and CSL partner to advance development and manufacture of COVID-19 vaccine candidate
|
|
05 Jun 2020 |
PDS Biotech Announces Clinical Trial of Its Lead Immunotherapy Product, PDS0101, in Combination with Chemoradiotherapy in Advanced Cervical Cancer
|
|
05 Jun 2020 |
Novavax Awarded Department of Defense Contract for COVID-19 Vaccine
|
|
05 Jun 2020 |
Intravacc Partners With Wageningen Bioveterinary Research and Utrecht University to Develop an Intranasal COVID-19 Vaccine
|
|
05 Jun 2020 |
AstraZeneca takes next steps towards broad and equitable access to Oxford University’s COVID-19 vaccine
|
|
04 Jun 2020 |
INOVIO and IVI Partner with Seoul National University Hospital to Start Phase 1/2 Clinical Trial of INOVIO's COVID-19 DNA Vaccine (INO-4800) in South Korea
|
|
03 Jun 2020 |
Intravacc and EpiVax Team up in Development of COVID-19 Emerging Vaccine
|
|
01 Jun 2020 |
Altimmune Launches Clinical Trial of T-COVIDTM, an Investigational Intranasal Immune Modulator for the Treatment of Patients with Early COVID-19
|
|
01 Jun 2020 |
Coronavirus Vaccine Development Underway by Vault Pharma
|
|
31 May 2020 |
Treos Bio Reports Positive Final Results of Phase I/II Off-The-Shelf CRC Cancer Immunotherapy in 2020 ASCO Poster Presentation
|
|
31 May 2020 |
MimiVax Phase 2 study of SurVaxM in combination with pembrolizumab opens for recurrent glioblastoma patients
|
|
30 May 2020 |
Moderna Announces First Participants in Each Age Cohort Dosed in Phase 2 Study of mRNA Vaccine (mRNA-1273) Against Novel Coronavirus
|
|
29 May 2020 |
Johnson & Johnson Receives Positive CHMP Opinion for Janssen’s Investigational Preventive Ebola Vaccine Regimen
|
|
29 May 2020 |
Clinical Response and Translational Data from DeCidE1, a Phase 2 Study of DPX-Survivac Immunotherapy in Patients with Advanced Recurrent Ovarian Cancer
|
